DOSSIER · 13F-HR · Q1 2026

Pacific Life Fund Advisors LLC

$871M in tracked AUM across 21 positions as of Q1 2026.

PL
CIK 0001499091 · last filed Mar 31, 2026
Total AUM
$871M
as of Q1 2026
Holdings
21
positions
Whale Score
76
76
strong
Activity
no data
changes this Q
AI Analysis · Q1 2026

Pacific Life Fund Advisors' Q1 2026 13F is a $871M, 21-position ETF-only portfolio that is unusually concentrated for an insurance-company asset manager — the top five iShares Russell-factor ETFs (IWD $171.7M, IWS $88.4M, IWN $81.3M, IWP $77.7M, IWO $63.5M) account for 55.4% of AUM on their own, giving the fund a small-and-mid-cap value-and-growth factor tilt that is more characteristic of a dedicated factor-timing vehicle than a generalist insurance-company book. The quarter's headline move is a $47.8M (-23.0% shares) reduction in IWD (iShares Russell 1000 Value, the portfolio's largest position) alongside a $17.5M increase in IWO (iShares Russell 2000 Growth, +42.0% shares) — a within-factor rotation from large-cap value to small-cap growth that is the most informative signal in the filing. The decreases are widespread: 16 of 21 positions were reduced in share terms, including IWS (mid-value -$11.3M, -14.2%), IWP (mid-growth -$11.6M, -7.0%), EFV (iShares MSCI EAFE Value -$11.5M, -28.2%), IEMG (EM -$5.4M but +8.1% shares — net mixed), TIP (inflation -$5.7M, -30.5%), AVIG (Avantis Intermediate-Term Fixed Income -$17.8M, -37.2%), and AVLV (large-cap value -$9.4M, -37.4%). The sole new open is EFG (iShares MSCI EAFE Growth, $13.0M) — an international-equity growth sleeve that had not been in the prior book. The increases, besides IWO, are IEMG (+8.1% shares, despite a dollar 'decrease' that reflects mark-to-market), AVUV (small-cap value +$2.5M, +22.7%), VONG (Nasdaq-100 growth +$1.4M fewer dollars but +7.0% shares), and AVEM (emerging-markets ex-China +$0.9M, +19.3%). The AUM dropped from $970.9M in Q4 2025 to $871M in Q1 2026 — a $100M AUM decline that is driving the across-the-board share reductions: the manager is scaling the portfolio down in proportion rather than making strategic sells. At a 78.25 whaleScore on $871M with a factor-ETF-only book, this is best read as an insurance-company sub-account that uses iShares and Avantis factor ETFs to implement a US small-and-mid-cap value-plus-growth mandate, with the Q1 delta reflecting a modest tactical tilt toward small-cap growth (IWO +42%) and international growth (EFG new) while the overall portfolio is shrinking in response to AUM outflows.

The portfolio's structural DNA is visible in the five core Russell-factor positions. IWD (iShares Russell 1000 Value, $171.7M, 19.7%) captures large-cap US value — the portfolio's largest position and the anchor of the US equity sleeve. IWS (iShares Russell Mid-Cap Value, $88.4M, 10.2%) and IWN (iShares Russell 2000 Value, $81.3M, 9.3%) extend the value factor down the capitalization ladder. IWP (iShares Russell Mid-Cap Growth, $77.7M, 8.9%) and IWO (iShares Russell 2000 Growth, $63.5M, 7.3%) provide the growth-factor complement at mid-and-small-cap. The five together create a 2×3 US factor matrix (large/mid/small × value/growth) that is the portfolio's core equity expression — the manager is not picking stocks or sectors but is systematically covering the US equity factor space through Russell-index ETFs with a slight value bias in the large-and-mid tiers (IWD+IWS larger than IWP+IWO) and a growth tilt at the small-cap tier (IWO increased at the expense of IWN).

The Q1 deltas must be read against the AUM context: the fund shrank from $970.9M in Q4 2025 to $871M in Q1 2026, a $100M decline that is roughly 10% of AUM. Most of the 16 share reductions across the 21-position book are proportional scale-backs rather than strategic sells. IWD's $47.8M and 239,169 share reduction (-23.0%) brings the position from 22.6% to 19.7% of AUM — a rebalancing back toward a target weight rather than a factor rotation away from large-cap value. IWS (-$11.3M, -14.2%), IWP (-$11.6M, -7.0%), and IWN (value, -$5.5M, -6.1%) were similarly reduced proportionally. The one exception to the proportional-reduction pattern is IWO (small-cap growth, +$17.5M, +42.0% shares) — the sole position that was increased in both dollar and share terms, which reflects a tactical factor-timing decision rather than an AUM-driven rebalancing. The manager is adding small-cap growth at the margin while reducing everything else, which is a meaningful relative-value signal.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
IWD
ISHARES TR
$172M803K19.7%
02
IWS
ISHARES TR
$88M607K10.2%
03
IWN
ISHARES TR
$81M429K9.3%
04
IWP
ISHARES TR
$78M607K8.9%
05
IWO
ISHARES TR
$63M202K7.3%
06
AVLC
AMERICAN CENTY ETF TR
$62M800K7.1%
07
IEMG
ISHARES INC
$50M711K5.7%
08
VONG
VANGUARD SCOTTSDALE FDS
$38M345K4.3%
09
AVDE
AMERICAN CENTY ETF TR
$36M422K4.1%
10
EFV
ISHARES TR
$34M461K3.9%

Filing history

2026Q1Mar 31
$871M 10.3%
21 positionsView →
2025Q4Dec 31
$971M 1252.8%
20 positionsView →
2025Q3Sep 30
$72M 92.3%
2 positionsView →
2025Q2Jun 30
$933M 1314.2%
20 positionsLocked
2025Q1Mar 31
$66M 93.2%
2 positionsLocked
2024Q4Dec 31
$964M 4.7%
22 positionsLocked
2024Q3Sep 30
$1.0B 1.0%
21 positionsLocked
2024Q2Jun 30
$1.0B 1.7%
22 positionsLocked
2024Q1Mar 31
$1.0B 2.0%
19 positionsLocked
2023Q4Dec 31
$999M 5.8%
20 positionsLocked
2023Q3Sep 30
$945M 4.0%
20 positionsLocked
2023Q2Jun 30
$984M 248.3%
19 positionsLocked
Showing 12 of 14